Anti-NMDAR encephalitis mimicking HaNDL syndrome

Cephalalgia

Volumn 34, Issue 12, 2014, Pages 1012-1014

  Finke, Carsten ^a   Mengel, Annerose ^a   Prüss, Harald ^a   Stöcker, Winfried ^b   Meisel, Andreas ^a   Ruprecht, Klemens ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Institute of Experimental Immunology   (Germany)

Author keywords

Anti NMDA receptor encephalitis; antibodies; headache with neurologic deficits and cerebrospinal fluid lymphocytosis (HaNDL)

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN G ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AGED; AGITATION; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; APHASIA; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CONFUSION; ELECTROENCEPHALOGRAM; HEADACHE WITH NEUROLOGICAL DEFICITS AND CEREBROSPINAL FLUID LYMPHOCYTOSIS; HEMIANOPIA; HEMIPARESIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LYMPHOCYTOSIS; MALE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PLASMAPHERESIS; PLEOCYTOSIS; RETROGRADE AMNESIA; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; CEREBROSPINAL FLUID; DIFFERENTIAL DIAGNOSIS; HEADACHE DISORDERS;

AGED; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; DIAGNOSIS, DIFFERENTIAL; HEADACHE DISORDERS; HUMANS; LYMPHOCYTOSIS; MALE;

EID: 84908206985     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102414526070     Document Type: Article

References (12)

1. Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011; 10: 63-74
2. Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: Temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain. 2010; 133 (Pt 6). 1655-1667
3. Reid DK, Clardy SL. Neurological picture. Anti-NMDA-receptor encephalitis: Unusual presentation of an uncommon condition. J Neurol Neurosurg Psychiatry. 2013; 84: 69-70
4. Rubio-Agustí I, Dalmau J, Sevilla T, et al. Isolated hemidystonia associated with NMDA receptor antibodies. Mov Disord. 2011; 26: 351-352
5. Gómez-Aranda F, Cañadillas F, Martí-Massó JF, et al. Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. A report of 50 cases. Brain. 1997; 120: 1105-1113
6. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629-808.
7. Parissis D, Ioannidis P, Balamoutsos G, et al. Confusional state in the syndrome of HaNDL. Headache. 2011; 51: 1285-1288
8. Kürtüncü M, Kaya D, Zuliani L, et al. CACNA1H antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL). Cephalalgia. 2013; 33: 123-129
9. Finke C, Kopp UA, Prüss H, et al. Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry. 2012; 83: 195-198
10. Titulaer MJ, Kayser MS, Dalmau J. Prevalence and treatment of anti-NMDA receptor encephalitis-Authors' reply. Lancet Neurol. 2013; 12: 425-426
11. Wandinger K-P, Saschenbrecker S, Stoecker W, et al. Anti-NMDA-receptor encephalitis: A severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol. 2011; 231: 86-91
12. Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med. 2011; 17: 439-447